Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Asahara, Takayuki  [Clear All Filters]
Journal Article
Kashiyama N, Miyagawa S, Fukushima S, Kawamura T, Kawamura A, Yoshida S, Nakamura Y, Harada A, Masuda H, Toda K, et al. Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts. PLoS One. 2019;14(5):e0217076.
Salybekov AA, Hassanpour M, Kobayashi S, Asahara T. Therapeutic application of regeneration-associated cells: a novel source of regenerative medicine. Stem Cell Res Ther. 2023;14(1):191.
Lee JHee, Ji STaek, Kim J, Takaki S, Asahara T, Hong Y-J, Kwon S-M. Specific disruption of Lnk in murine endothelial progenitor cells promotes dermal wound healing via enhanced vasculogenesis, activation of myofibroblasts, and suppression of inflammatory cell recruitment. Stem Cell Res Ther. 2016;7(1):158.
Wolfien M, Klatt D, Salybekov AA, Ii M, Komatsu-Horii M, Gaebel R, Philippou-Massier J, Schrinner E, Akimaru H, Akimaru E, et al. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3. EBioMedicine. 2020;57:102862.
Kwon S-M, Lee J-H, Lee S-H, Jung S-Y, Kim D-Y, Kang S-H, Yoo S-Y, Hong J-K, Park J-H, Kim J-H, et al. Cross Talk with Hematopoietic Cells Regulates the Endothelial Progenitor Cell Differentiation of CD34 Positive Cells. PLoS One. 2014;9(8):e106310.
Hassanpour M, Salybekov AA, Kobayashi S, Asahara T. CD34 positive cells as endothelial progenitor cells in biology and medicine. Front Cell Dev Biol. 2023;11:1128134.
Lee JHee, Lee SHun, Yoo SYoung, Asahara T, Kwon SMo. CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases. Arterioscler Thromb Vasc Biol. 2013.